Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.23% | -12.75% | 13.34% | 1.45% | -8.72% |
| Total Depreciation and Amortization | -6.96% | 26.88% | 92.49% | 107.16% | 120.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 572.88% | 538.15% | 384.64% | 155.11% | 56.75% |
| Change in Net Operating Assets | -111.64% | -1,736.12% | -575.33% | -489.52% | -350.74% |
| Cash from Operations | 30.28% | 22.48% | 14.51% | 2.37% | -8.50% |
| Capital Expenditure | 86.61% | 25.17% | -128.09% | -45.16% | -6.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.65% | -1,560.00% | -209.52% | -165.34% | -145.82% |
| Cash from Investing | 86.15% | 23.73% | -139.74% | -52.68% | -11.91% |
| Total Debt Issued | -- | 40.92% | -70.04% | -85.02% | -- |
| Total Debt Repaid | 54.91% | 35.40% | 6.68% | -68.28% | -242.93% |
| Issuance of Common Stock | -26.10% | -26.60% | -27.09% | -38.26% | -44.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.54% | 38.46% | -26.22% | -82.36% | -195.30% |
| Cash from Financing | 60.33% | -6.43% | -45.37% | -55.75% | -63.74% |
| Foreign Exchange rate Adjustments | -21.11% | 567.61% | 397.76% | 49.85% | -61.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.50% | 48.72% | -103.69% | -1,075.59% | -267.37% |